Re-biopsy in a patient with IgA nephropathy showing success of treatment with cyclosporin A and angiotensin-II receptor blocker

[1]  G. Signoriello,et al.  Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Y. Kobayashi,et al.  Clinical and histological improvement with long-term, low-dose cyclosporin A in a patient with severe IgA nephropathy , 2001, Clinical and Experimental Nephrology.

[3]  N. Yoshikawa,et al.  Pathophysiology and treatment of IgA nephropathy in children , 2001, Pediatric Nephrology.

[4]  V. Tesar,et al.  LONG TERM TREATMENT OF IgA NEPHROPATHY WITH CYCLOSPORINE A , 2000, Renal failure.

[5]  N. Perico,et al.  The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. , 1998, Journal of the American Society of Nephrology : JASN.

[6]  D. B. Lee,et al.  Cyclosporine and the renin-angiotensin axis. , 1997, Kidney international.

[7]  B. Myers,et al.  Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.

[8]  D. Cattran.  Use of cyclosporin in membranous and mesangioproliferative (IgA) nephropathy. , 1995, Contributions to Nephrology.

[9]  M. Daha,et al.  CsA, FK506, corticosteroids and rapamycin inhibit TNFα production by cultured PTEC , 1993 .

[10]  J. Mason.  Renal side‐effects of cyclosporin A , 1990, The British journal of dermatology.

[11]  G. Remuzzi,et al.  Renal vascular and thrombotic effects of cyclosporine. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  F. Schena,et al.  Increased production of interleukin-2 and IL-2 receptor in primary IgA nephropathy. , 1989, Kidney international.

[13]  F. Lai,et al.  Cyclosporin treatment of IgA nephropathy: a short term controlled trial. , 1987, British medical journal.

[14]  F. Lai,et al.  Effect of cyclosporine a on circulating immune complexes in IgA nephropathy , 2006, International Urology and Nephrology.

[15]  A. J. López,et al.  Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level. , 1999, Mediators of inflammation.

[16]  K. Resch,et al.  Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. , 1994, Kidney international.

[17]  S. K. Lee,et al.  Immunologic and morphologic study of experimental IgA nephropathy in ddY mice after administration of cyclosporin A(CsA). , 1992 .